Literature DB >> 10525979

The diagnostic accuracy of magnetic resonance imaging and cerebrospinal fluid cytology in leptomeningeal metastasis.

C S Straathof1, H G de Bruin, D W Dippel, C J Vecht.   

Abstract

Diagnostic decision making in the case of patients suspected of having leptomeningeal metastasis (LM) can be very difficult. The results of cerebrospinal fluid (CSF) cytology can be repeatedly negative, and the predictive value of gadolinium-enhanced magnetic resonance imaging (MRI) is not well known. We report the results of CSF cytology and Gd MRI in 61 patients with known cancer, suspected of having LM. We combined our data with those from a similar study and calculated the sensitivity and specificity of CSF and Gd MRI, in the absence of a "gold standard diagnosis." CSF cytology was positive for LM in 35 patients and MRI in 38. With CSF cytology sensitivity 75% and specificity 100%, with Gd MRI sensitivity was 76% but specificity only 77%. We conclude that Gd MRI provides strong support in the diagnosis of LM in patients with cancer who have negative results on CSF cytology.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10525979     DOI: 10.1007/s004150050459

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  60 in total

1.  Clinical and radiological response of leptomeningeal melanoma after whole brain radiotherapy and ipilimumab.

Authors:  I Bot; C U Blank; D Brandsma
Journal:  J Neurol       Date:  2012-04-18       Impact factor: 4.849

2.  Clinical Reasoning: Worsening neurologic symptoms in a brain tumor patient.

Authors:  Geraldine Faivre; Elena Pentsova; Alexis Demopoulos; Sophie Taillibert; Marc Rosenblum; Antonio Omuro
Journal:  Neurology       Date:  2015-08-18       Impact factor: 9.910

3.  Case 10: it's "the vision thing".

Authors:  Daniel S Reich
Journal:  MedGenMed       Date:  2005-07-26

4.  Leptomeningeal metastasis from ovarian carcinoma successfully treated by the intraventricular administration of methotrexate.

Authors:  Yasushi Goto; Noriyuki Katsumata; Shunichi Nakai; Yuko Sasajima; Kan Yonemori; Tsutomu Kouno; Chikako Shimizu; Masashi Ando; Yasuhiro Fujiwara
Journal:  Int J Clin Oncol       Date:  2008-12-18       Impact factor: 3.402

5.  An extremely rare case of pancreatic cancer presenting with leptomeningeal carcinomatosis and synchronous intraparenchymal brain metastasis.

Authors:  Rohit Rao; Santhosh K Sadashiv; Swapna Goday; Dulabh Monga
Journal:  Gastrointest Cancer Res       Date:  2013-05

6.  11C-methionine PET imaging of leptomeningeal metastases from primary breast cancer--a case report.

Authors:  M V Padma; M Jacobs; G Kraus; M Collins; K Dunigan; J Mantil
Journal:  J Neurooncol       Date:  2001-10       Impact factor: 4.130

7.  The clinical experience of medulloblastoma treatment and the significance of time sequence for development of leptomeningeal metastasis.

Authors:  Po-Chuan Hsieh; Chieh-Tsai Wu; Kuang-Lin Lin; Tang-Her Jaing; Chen-Kan Tseng; Tai-Ngar Lui; Shih-Ming Jung
Journal:  Childs Nerv Syst       Date:  2008-09-19       Impact factor: 1.475

8.  Leptomeningeal carcinomatosis as the only manifestation of disease in recurrent gastroesophageal cancers.

Authors:  Syed Rizvi; Salman Fateh; Kamal K S Abbi; Yixing Jiang
Journal:  Gastrointest Cancer Res       Date:  2011-03

9.  The value of tandem CSF/MRI evaluation for predicting disseminated disease in childhood central nervous system neoplasms.

Authors:  Judy Pang; Anuradha Banerjee; Tarik Tihan
Journal:  J Neurooncol       Date:  2007-11-07       Impact factor: 4.130

Review 10.  Leptomeningeal metastases from prostate cancer: an emerging clinical conundrum.

Authors:  George Orphanos; Alexandros Ardavanis
Journal:  Clin Exp Metastasis       Date:  2009-11-11       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.